Cancer claims

Bayer (BAYGn.DE) won a significant legal victory in its ongoing effort to limit liability from claims that its Roundup weed killer causes cancer. On Thursday, a U.S. appeals court ruled that federal law protects the German company from a lawsuit filed by a Pennsylvania landscaper. Following the decision, Bayer’s shares surged as much as 13.2%…